Statement Of Investor Complaints For The Quarter Ended June 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0110 Name of the Signatory :- Trivikram GudaDesignation :- Company Secretary and Compliance Officer Drug regulator cancels licence of Novartis' painkiller diclofenac over safety concerns
The watchdog directed Dehradun, Uttarakhand and Daman and Diu's drug license authority to cancel the license of Themis Medicare. Announcement Under Regulation 30 - Update With Respect To A Newspaper Publication In Mint On July 12, 2018
This letter has a reference to a newspaper publication in 'Mint' on July 12, 2018 regarding issuance of a show cause notice by drug licensing authority to Themis Medicare Limited (Themis), who is a manufacturer of Diclofenac 1 ml injection for Novartis India Limited (Company). In this context, it may be noted that Themis has intimated the Company on July 12, 2018 that they are in receipt of a show cause notice dated July 11, 2018 from...
Drug regulator orders recall of Novartis's painkiller diclofenac
Drug controller general of India (DCGI )cancels licence for diclofenac sold by Novartis after concerns raised by a health ministry panel Corporate Action : Fixed Book Closure
In continuation to our letter dated May 10, 2018 regarding Book Closure dates (from July 20, 2018 to July 27, 2018 - both days inclusive) it may be noted that, the dividend if declared by the shareholders at the ensuing AGM on July 27, 2018, will be paid on and from August 1, 2018 to those shareholders whose name appears in the Register of Members as on July 19, 2018.... Announcement under Regulation 30 (LODR)-Newspaper Publication
Publication of Notice of 70th Annual General Meeting of the Company in newspapers Dear Sirs, Apropos the subject matter quoted above, please find enclosed herewith the copies of the Notice of 70th Annual General Meeting of the Company published in the Newspapers viz. 'Financial Express' and 'Navshakti' on July 03, 2018. This is for your information and record. Thanking You. Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement of Notice of Board Meeting to be held on July 26, 2018 In continuation to our letter dated June 27, 2018 please find enclosed copies of Notice of Board Meeting that was published in the Financial Express and Navshakti today. The Board Meeting of the Company is scheduled to be held on Thursday, July 26, 2018. The same has been made available on the website of the Company www.novartis.in. Board Meeting On July 26, 2018
Dear Sirs, Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Thursday, July 26, 2018; inter-alia to consider unaudited financial results of the Company for the first quarter ended June 30, 2018.... Regulation 30 Of SEBI (LODR) Regulations, 2015 & SEBI Circular Dated September 09, 2015
This is in reference to your email dated May 18, 2018 regarding our letter dated May 10, 2018 pertaining to the outcome of Board Meeting wherein Mr. Milan Paleja was appointed as the Vice Chairman & Managing Director of the Company with effect from June 1, 2018 for a period of 5 years subject to the approval of the Shareholders and Central Government.... Announcement under Regulation 30 (LODR)-Newspaper Publication
Notice to Shareholders: Transfer of Equity Shares to Investor Education and Protection Fund Suspense Account